Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
Patents for A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics (179,784)
05/2000
05/31/2000DE19854356A1 Kristallmodifikation A von A crystal modification of 8-Cyan-1-cyclopropyl-7-(1S,6S-2,8-diazabicyclo-/4.3.0/nonan-8-yl)-6-fluor-1,4-dihydro-4-oxo-3-chinolincarbonsäure
05/31/2000DE19854355A1 Kristallmodifikation B von 8-Cyan-1-cyclopropyl-7-(1S, 6S-2,8-diazabicyclo-/4.3.O/nonan-8-yl)-6-fluor-1,4-dihydro-4-oxo-3-chinolincarbonsäure Crystal modification B of 8-cyano-1-cyclopropyl-7- (1S, 6S-2,8-diazabicyclo / 4.3.O / nonan-8-yl) -6-fluoro-1,4-dihydro-4-oxo- 3-quinolinecarboxylic acid
05/31/2000CN1255063A Photosensitizer conjugates for pathogen targeting
05/31/2000CN1255060A Pharmaceutical compositions of tizoxanide and nitazoxanide
05/31/2000CN1254756A Attenuated virus of ox's viral diarrhea
05/31/2000CN1254587A Broad-spectrum antibacterial medicine
05/31/2000CN1254559A Broad-spectrum antibacterial medicine and its exterior application method
05/31/2000CN1053012C Hog choera virus vaccine and diagnostic
05/31/2000CN1052984C New erythromycin derivative and its preparing process and application in medicine
05/31/2000CN1052903C Chinese medicine composite for preventing dental caries
05/31/2000CN1052902C Method for preparation of drug for curing acute epidemic febrile disease
05/31/2000CN1052900C Antisepsis, anti-inflammation and hemostasis capsules
05/31/2000CN1052897C Oral liquid for curing cold and preparation technology thereof
05/30/2000US6069160 Heteroatom-containing benzocyclopentane-oxazolidinones
05/30/2000US6069145 Piperazinonephenyloxazolidinone derivatives and their use as antibacterial agents
05/30/2000US6069141 Substituted aminophenyl isoxazoline derivatives useful as antimicrobials
05/30/2000US6069127 Human infant formula containing a glycoprotein specific for binding to the human mac-2 (macrophage antigen) lectin; to prevent infections
05/30/2000US6068992 Production of gonorrheal PI proteins and vaccines
05/30/2000US6068983 Introducing into cells a dna molecule coding for an fc receptor which is then expressed for increased phagocytic activity; combating infection and/or modulating immune complex disease
05/30/2000US6068973 Suppressing transmission of influenza a virus to cell by contacting cell with influenza virus peptide of specific sequence chosen by a computer algorithm
05/30/2000US6068972 Screening by contacting microorganisms with organic solvent, determining expression of acr-like efflux pump gene locus, comparing to control, altered expression indicates activation of multiple antibiotic resistance phenotype
05/30/2000US6068860 For topical administration comprising foscarnet and an antiinflammatory glucocorticoid, with a carrier based on galactolipids comprising digalactosyldiacylglycerols, and a polar solvent; treating herpes infections
05/30/2000US6068859 Controlled-release dosage forms of Azithromycin
05/30/2000US6068856 Oral pharmaceutical composition with delayed release of active ingredient for pantoprazole
05/30/2000US6068851 Formulation for use in the prevention of pathogen induced diseases including HIV and HSV
05/30/2000US6068842 A polypeptide containing 66 kda protein of borrelia afzelli
05/30/2000US6068841 Antibodies to Fas-L for treatment of hepatitis
05/30/2000US6068839 Antibiotics TKR1912-I and TKR1912-II and process for producing the same
05/30/2000CA2142862C Method for inhibiting hiv replication using il-4
05/30/2000CA2083333C High dosage topical forms of collagenase
05/30/2000CA2026570C Method for production and purification of hepatitis b vaccine
05/30/2000CA2024880C 10-(1-hydroxyethyl)-11-oxo-1-azatricyclo(7.2.0.0.3,8)undec-2-ene-2-2-ca rboxylic acid derivatives
05/30/2000CA2012226C Olefinic 1h-imidazo [4,5-c]quinolin-4-amines
05/26/2000CA2252967A1 Protein fragments for use in protein targeting
05/26/2000CA2252966A1 Viral therapeutics
05/25/2000WO2000029598A1 Novel recombinant adenovirus
05/25/2000WO2000029590A1 Method for identifying inhibitors of ipc synthase
05/25/2000WO2000029588A1 Lysozyme fusion proteins in infections
05/25/2000WO2000029583A2 Immunoglobulin superfamily proteins
05/25/2000WO2000029551A2 Cells, culture methods, and their use in autologous transplantation therapy
05/25/2000WO2000029477A1 Poly(alpha-1,4-d-glucan) and thermoplastic polymer mixtures containing the same
05/25/2000WO2000029446A1 Method for inhibiting macrophage infiltration using monoclonal anti-alpha-d-antibodies
05/25/2000WO2000029435A1 12 human secreted proteins
05/25/2000WO2000029432A1 Heliobacter pylori antigen
05/25/2000WO2000029422A1 31 human secreted proteins
05/25/2000WO2000029401A1 Hydroxamic and carboxylic acid derivatives having mmp and tnf inhibitory activity
05/25/2000WO2000029396A1 Novel substituted phenyloxazolidone derivatives
05/25/2000WO2000029390A1 Crystalline (-)-6- chloro-4- cyclopropylethynyl- 4-trifluoromethyl- 3,4-dihydro- 2(1h)-quinazolinone
05/25/2000WO2000029389A1 6-(3-carboxymethylphenyl)-aminouracyl having a biological activity
05/25/2000WO2000029385A1 1,4,5,6-tetrahydro-pyridazine derivatives, their preparation and their use as neuraminidase inhibitors
05/25/2000WO2000029384A1 2-phenylbenzimidazoles and 2-phenylindoles, and production and use thereof
05/25/2000WO2000029377A1 4-aroyl-piperidin-ccr-3 receptor antagonists iii
05/25/2000WO2000029027A1 Antiviral formulations comprising propylene glycol and an isopropyl alkanoic acid ester
05/25/2000WO2000029018A1 Combined vaccine against both hav and measle virus and method of producing it
05/25/2000WO2000029017A1 Mycobacterium tuberculosis superoxide dismutase
05/25/2000WO2000029016A1 Intradermal avian immunization with inactivated vaccines
05/25/2000WO2000029008A2 Hiv-specific t-cell induction
05/25/2000WO2000028998A1 Liquid ophthalmic preparations
05/25/2000WO2000028994A1 Copolymer compositions for treating viral infections
05/25/2000WO2000028988A1 Nitrosated and nitrosylated h2 receptor antagonist compounds, compositions and methods of use
05/25/2000WO2000028983A1 Novel 4-dedimethy laminotetra cycline derivatives
05/25/2000WO2000028947A2 Use of a substance binding with the peripheral benzodiazepin receptor for treating skin stress
05/25/2000WO2000028942A1 Process for the manufacture of liquid filled capsules
05/25/2000WO2000028821A1 Therapeutic anti-fungal nail preparation
05/25/2000WO2000028815A1 Aromatic copolyester containing active ingredients
05/25/2000WO2000017233A3 Genes of the 1-desoxy-d-xylulose biosynthetic pathway
05/25/2000WO2000016755A3 Antiviral combinations of lamivudine and adefovir
05/25/2000WO2000015798A3 Mammalian transforming growth factor beta - 9 (ztgfss9)
05/25/2000WO2000015210A3 Use of mycophenol acid and its derivatives for the treatment of virus diseases
05/25/2000WO2000012049A3 A method for the treatment of staphylococcal disease
05/25/2000WO2000009543A3 Hepatitis c inhibitor tri-peptides
05/25/2000DE19955793A1 CCR-3-Rezeptor-Antagonisten CCR-3 receptor antagonists
05/25/2000DE19937794A1 Composition useful for promoting wound healing comprises eugenol and polyphenols
05/25/2000DE19850986A1 Die gentechnische Prägung von Zellen und ihre Verwendung zur Prophylaxe und Therapie von Erkrankungen The genetic imprint of cells and their use in the prophylaxis and treatment of diseases
05/25/2000DE19844022C1 Use of iron-binding glycoproteins and/or 10-hydroxy-2-decenoic acid in combination with thymoquinone for treating immunodeficiency diseases
05/25/2000DE19840263C1 Papillomviren, Mittel zu deren Nachweis sowie zur Therapie von durch sie verursachten Erkrankungen Papillomaviruses means for their detection as well as for the treatment of diseases caused by them
05/25/2000CA2351516A1 Copolymer compositions for treating viral infections
05/25/2000CA2351314A1 Novel recombinant adenovirus
05/25/2000CA2350911A1 Hiv-specific t-cell induction
05/25/2000CA2350785A1 31 human secreted proteins
05/25/2000CA2350722A1 4-aroyl-piperidin-ccr-3 receptor antagonists iii
05/25/2000CA2350391A1 Method for inhibiting macrophage infiltration using monoclonal anti-alpha-d-antibodies
05/25/2000CA2349919A1 Use of a substance binding with the peripheral benzodiazepin receptor for treating skin stress
05/25/2000CA2349837A1 Lysozyme fusion proteins in infections
05/25/2000CA2349575A1 Nitrosated and nitrosylated h2 receptor antagonist compounds, compositions and methods of use
05/25/2000CA2349431A1 Intradermal avian immunization with inactivated vaccines
05/25/2000CA2348824A1 12 human secreted proteins
05/25/2000CA2348459A1 Hydroxamic and carboxylic acid derivatives having mmp and tnf inhibitory activity
05/25/2000CA2345516A1 Crystalline (-)-6- chloro-4- cyclopropylethynyl- 4-trifluoromethyl- 3,4-dihydro- 2(1h)-quinazolinone
05/25/2000CA2343946A1 Poly(alpha-1,4-d-glucan) and thermoplastic polymer mixtures containing the same
05/24/2000EP1002795A1 HIV Replication inhibiting pyrimidines
05/24/2000EP1002541A1 Oral drugs for amelioration of aids symptoms
05/24/2000EP1002534A1 Bis-Staurosporine and K-252a derivatives
05/24/2000EP1002112A1 Agent for expressing and detecting a fusion polypeptide with an hpol-epitope and a polypeptide
05/24/2000EP1002110A1 Immune responses against hpv antigens elicited by compositions comprising an hpv antigen and a stress protein or an expression vector capable of expression of these proteins
05/24/2000EP1002108A2 Use of mhc class ii ligands as adjuvant for vaccination and of lag-3 in cancer treatment
05/24/2000EP1002093A1 Preparation and use of recombinant influenza a virus m2 constructs and vaccines
05/24/2000EP1002092A1 Mimotopes of hypervariable region 1 of the e2 glycoprotein of hcv and uses thereof
05/24/2000EP1002090A2 $i(ENTEROCOCCUS FAECALIS) POLYNUCLEOTIDES AND POLYPEPTIDES
05/24/2000EP1002082A2 Transcriptional silencer protein nrf
1 ... 1459 1460 1461 1462 1463 1464 1465 1466 1467 1468 1469 1470 1471 1472 1473 1474 1475 1476 1477 1478 1479 ... 1798